Cargando…

Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment

OBJECTIVE: Spinal muscular atrophy (SMA) is a neurodegenerative disorder characterized by the degeneration of motor neurons in the spinal cord. It remains uncertain whether the cognitive performance of adult patients with SMA is impaired. The objective of this study was to assess the cognitive profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ying, Wei, Ling, Li, Aonan, Liu, Tingting, Jiang, Yubao, Xie, Chengjuan, Wang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655145/
https://www.ncbi.nlm.nih.gov/pubmed/38020636
http://dx.doi.org/10.3389/fneur.2023.1226043
_version_ 1785136761943359488
author Hu, Ying
Wei, Ling
Li, Aonan
Liu, Tingting
Jiang, Yubao
Xie, Chengjuan
Wang, Kai
author_facet Hu, Ying
Wei, Ling
Li, Aonan
Liu, Tingting
Jiang, Yubao
Xie, Chengjuan
Wang, Kai
author_sort Hu, Ying
collection PubMed
description OBJECTIVE: Spinal muscular atrophy (SMA) is a neurodegenerative disorder characterized by the degeneration of motor neurons in the spinal cord. It remains uncertain whether the cognitive performance of adult patients with SMA is impaired. The objective of this study was to assess the cognitive profile of adult Chinese patients with SMA and the association between clinical features and cognitive ability, particularly executive function. METHODS: This cross-sectional study included 22 untreated adult patients with type III SMA and 20 healthy subjects. The following variables were assessed: general intelligence, memory, attention, language, executive function, depression, anxiety, and other demographic and clinical parameters. In addition, physical function was evaluated using the Hammersmith Functional Motor Scale Expanded (HFMSE), the Revised Upper Limb Module (RULM), and the 6-Minute Walk Test (6MWT). RESULTS: SMA patients had lower scores than healthy subjects in the Verbal Fluency Test, Stroop effect, Total Errors, Perseverative Responses, Perseverative Errors, and Non-perseverative Errors in the Wisconsin Card Sorting Test, showing impaired abilities of SMA patients in executive function. In the Attention Network Test (ANT), the results indicated that the SMA patients also had selective deficits in their executive control networks. Ambulant patients had better executive function test performance than non-ambulant ones. Compromised executive abilities in patients with SMA were correlated with a younger age at onset, poorer motor function, and higher levels of anxiety and depression. CONCLUSION: Our study presented the distribution of cognitive impairment in a Chinese cohort with SMA. Patients with type III SMA showed selective deficits in executive function, which may be associated with disease severity, physical impairment, depression and anxiety. Future cognitive studies, accounting for motor and emotional impairment, are needed to evaluate if executive impairment is driven by specific brain changes or by those confounding factors.
format Online
Article
Text
id pubmed-10655145
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106551452023-11-03 Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment Hu, Ying Wei, Ling Li, Aonan Liu, Tingting Jiang, Yubao Xie, Chengjuan Wang, Kai Front Neurol Neurology OBJECTIVE: Spinal muscular atrophy (SMA) is a neurodegenerative disorder characterized by the degeneration of motor neurons in the spinal cord. It remains uncertain whether the cognitive performance of adult patients with SMA is impaired. The objective of this study was to assess the cognitive profile of adult Chinese patients with SMA and the association between clinical features and cognitive ability, particularly executive function. METHODS: This cross-sectional study included 22 untreated adult patients with type III SMA and 20 healthy subjects. The following variables were assessed: general intelligence, memory, attention, language, executive function, depression, anxiety, and other demographic and clinical parameters. In addition, physical function was evaluated using the Hammersmith Functional Motor Scale Expanded (HFMSE), the Revised Upper Limb Module (RULM), and the 6-Minute Walk Test (6MWT). RESULTS: SMA patients had lower scores than healthy subjects in the Verbal Fluency Test, Stroop effect, Total Errors, Perseverative Responses, Perseverative Errors, and Non-perseverative Errors in the Wisconsin Card Sorting Test, showing impaired abilities of SMA patients in executive function. In the Attention Network Test (ANT), the results indicated that the SMA patients also had selective deficits in their executive control networks. Ambulant patients had better executive function test performance than non-ambulant ones. Compromised executive abilities in patients with SMA were correlated with a younger age at onset, poorer motor function, and higher levels of anxiety and depression. CONCLUSION: Our study presented the distribution of cognitive impairment in a Chinese cohort with SMA. Patients with type III SMA showed selective deficits in executive function, which may be associated with disease severity, physical impairment, depression and anxiety. Future cognitive studies, accounting for motor and emotional impairment, are needed to evaluate if executive impairment is driven by specific brain changes or by those confounding factors. Frontiers Media S.A. 2023-11-03 /pmc/articles/PMC10655145/ /pubmed/38020636 http://dx.doi.org/10.3389/fneur.2023.1226043 Text en Copyright © 2023 Hu, Wei, Li, Liu, Jiang, Xie and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Hu, Ying
Wei, Ling
Li, Aonan
Liu, Tingting
Jiang, Yubao
Xie, Chengjuan
Wang, Kai
Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment
title Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment
title_full Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment
title_fullStr Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment
title_full_unstemmed Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment
title_short Cognitive impairment in Chinese adult patients with type III spinal muscular atrophy without disease-modifying treatment
title_sort cognitive impairment in chinese adult patients with type iii spinal muscular atrophy without disease-modifying treatment
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655145/
https://www.ncbi.nlm.nih.gov/pubmed/38020636
http://dx.doi.org/10.3389/fneur.2023.1226043
work_keys_str_mv AT huying cognitiveimpairmentinchineseadultpatientswithtypeiiispinalmuscularatrophywithoutdiseasemodifyingtreatment
AT weiling cognitiveimpairmentinchineseadultpatientswithtypeiiispinalmuscularatrophywithoutdiseasemodifyingtreatment
AT liaonan cognitiveimpairmentinchineseadultpatientswithtypeiiispinalmuscularatrophywithoutdiseasemodifyingtreatment
AT liutingting cognitiveimpairmentinchineseadultpatientswithtypeiiispinalmuscularatrophywithoutdiseasemodifyingtreatment
AT jiangyubao cognitiveimpairmentinchineseadultpatientswithtypeiiispinalmuscularatrophywithoutdiseasemodifyingtreatment
AT xiechengjuan cognitiveimpairmentinchineseadultpatientswithtypeiiispinalmuscularatrophywithoutdiseasemodifyingtreatment
AT wangkai cognitiveimpairmentinchineseadultpatientswithtypeiiispinalmuscularatrophywithoutdiseasemodifyingtreatment